You just read:

Data Presented at AAAAI Annual Meeting Further Support the Safety and Efficacy of FIRAZYR® (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema

News provided by

Shire plc

Mar 22, 2011, 07:00 ET